UK122 is a potent and selective inhibitor of urokinase-type plasminogen activator (uPA) (IC50 = 0.2 μM); it shows no or minimal inhibition against tissue-type plasminogen activator (tPA), plasmin, thrombin, and trypsin (IC50 > 100 μM); it is an oxazolidinone analog with anticancer activity, inhibiting cancer cell migration and invasion.